Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Atrion Corporation (ATRI)

    Price:

    459.92 USD

    ( + 0.26 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    ATRI
    Name
    Atrion Corporation
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    Price
    459.920
    Market Cap
    809.436M
    Enterprise value
    663.724M
    Currency
    USD
    Ceo
    David A. Battat
    Full Time Employees
    712
    Ipo Date
    1980-03-18
    City
    Allen
    Address
    One Allentown Parkway

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Akoya Biosciences, Inc.

    VALUE SCORE:

    0

    Symbol
    AKYA
    Market Cap
    64.441M
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    2nd position

    LeMaitre Vascular, Inc.

    VALUE SCORE:

    9

    Symbol
    LMAT
    Market Cap
    2.271B
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    The best

    Pro-Dex, Inc.

    VALUE SCORE:

    10

    Symbol
    PDEX
    Market Cap
    150.089M
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    253.575
    P/S
    8.422
    P/B
    3.391
    Debt/Equity
    0
    EV/FCF
    46.887
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    8.303
    Earnings yield
    0.004
    Debt/assets
    0
    FUNDAMENTALS
    Net debt/ebidta
    -0.996
    Interest coverage
    0
    Research And Developement To Revenue
    0.031
    Intangile to total assets
    0.041
    Capex to operating cash flow
    0.243
    Capex to revenue
    0.057
    Capex to depreciation
    0.686
    Return on tangible assets
    0.013
    Debt to market cap
    0
    Piotroski Score
    6.000
    FUNDAMENTALS
    PEG
    -7.709
    P/CF
    36.030
    P/FCF
    47.561
    RoA %
    1.227
    RoIC %
    1.341
    Gross Profit Margin %
    29.340
    Quick Ratio
    2.944
    Current Ratio
    6.801
    Net Profit Margin %
    3.323
    Net-Net
    28.303
    FUNDAMENTALS PER SHARE
    FCF per share
    9.664
    Revenue per share
    54.575
    Net income per share
    1.814
    Operating cash flow per share
    12.765
    Free cash flow per share
    9.664
    Cash per share
    9.986
    Book value per share
    135.646
    Tangible book value per share
    129.545
    Shareholders equity per share
    135.646
    Interest debt per share
    0
    TECHNICAL
    52 weeks high
    503.240
    52 weeks low
    274.980
    Current trading session High
    460.260
    Current trading session Low
    459.750
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    242%
    Years of div. Increase
    1.000
    Years of div.
    22.000
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.348

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -11.393
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0.012727144%
    Payout Ratio
    29.863014999999997%
    P/E
    23.890
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -49.260
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    36.302
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    16.604
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -85.496
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -44.812
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    44.410
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.031

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Equipment & Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    68.228
    DESCRIPTION

    Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

    NEWS
    https://images.financialmodelingprep.com/news/smaller-but-mighty-3-smallcap-stocks-for-longterm-dividend-20240814.jpg
    Smaller But Mighty: 3 Small-Cap Stocks for Long-Term Dividend Growth

    investorplace.com

    2024-08-14 07:30:00

    Generally speaking, small-cap stocks have market capitalizations below $2 billion. They tend to have stronger growth potential over the long run when compared to bigger companies in their respective industries.

    https://images.financialmodelingprep.com/news/atrions-atri-q2-earnings-plummet-yy-on-nordson-merger-costs-20240809.jpg
    Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs

    zacks.com

    2024-08-09 14:20:24

    Atrion's (ATRI) Q2 EPS drops to 23 cents, down from $3.73 year over year, as merger-related expenses with Nordson hit profits despite strong revenue growth in MPS and fluid delivery segments.

    https://images.financialmodelingprep.com/news/atrion-reports-second-quarter-2024-results-20240808.jpg
    Atrion Reports Second Quarter 2024 Results

    globenewswire.com

    2024-08-08 18:00:00

    ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024.

    https://images.financialmodelingprep.com/news/atri-alert-the-ma-class-action-firm-investigates-the-20240729.jpg
    ATRI ALERT: The M&A Class Action Firm Investigates the Merger and August 19, 2024 Shareholder Vote of Atrion Corporation

    prnewswire.com

    2024-07-29 09:17:00

    NEW YORK , July 29, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

    https://images.financialmodelingprep.com/news/shareholder-investigation-halper-sadeh-llc-investigates-atri-calt-on-20240728.jpg
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders

    accesswire.com

    2024-07-28 12:40:00

    NEW YORK, NY / ACCESSWIRE / July 28, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Atrion Corporation (NASDAQ: ATRI)'s sale to Nordson Corporation for $460.00 per share in cash. If you are an Atrion shareholder, click here to learn more about your legal rights and options.

    https://images.financialmodelingprep.com/news/shareholder-investigation-halper-sadeh-llc-investigates-atri-htlf-on-20240717.jpg
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, HTLF on Behalf of Shareholders

    globenewswire.com

    2024-07-17 17:29:00

    NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

    https://images.financialmodelingprep.com/news/urgent-update-the-ma-class-action-firm-investigates-merger-20240716.jpg
    URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation – ATRI

    globenewswire.com

    2024-07-16 17:08:00

    NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. ( Nasdaq : ATRI ), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of Atrion stock they hold.

    https://images.financialmodelingprep.com/news/urgent-update-the-ma-class-action-firm-investigates-merger-20240715.jpg
    URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation - ATRI

    prnewswire.com

    2024-07-15 20:36:00

    NEW YORK , July 15, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

    https://images.financialmodelingprep.com/news/shareholder-investigation-the-ma-class-action-firm-investigates-merger-of-20240708.jpg
    SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation – ATRI

    globenewswire.com

    2024-07-08 15:13:00

    NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. ( Nasdaq : ATRI ), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of Atrion stock they hold.

    https://images.financialmodelingprep.com/news/shareholder-investigation-the-ma-class-action-firm-investigates-merger-of-20240703.jpg
    SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation - ATRI

    prnewswire.com

    2024-07-03 20:26:00

    NEW YORK , July 3, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

    https://images.financialmodelingprep.com/news/zacks-initiates-coverage-of-atrion-with-neutral-recommendation-20240607.jpg
    Zacks Initiates Coverage of Atrion With Neutral Recommendation

    zacks.com

    2024-06-07 08:46:15

    Discover why Zacks gives Atrion a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Uncover ATRI's impressive growth in the medical devices market and strong financials, alongside challenges like stiff competition in the medical devices market.

    https://images.financialmodelingprep.com/news/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-20240528.jpg
    ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Atrion Corporation

    prnewswire.com

    2024-05-28 17:45:00

    NEW YORK , May 28, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Atrion Corporation (NASDAQ: ATRI) and its board of directors concerning the proposed acquisition of the company by Nordson Corporation. Stockholders will receive $460 for each share of Atrion stock that they hold.

    https://images.financialmodelingprep.com/news/shareholder-alert-ademi-llp-investigates-whether-atrion-corporation-has-20240528.jpg
    Shareholder Alert: Ademi LLP investigates whether Atrion Corporation has obtained a Fair Price for its Public Shareholders in its transaction with Nordson

    prnewswire.com

    2024-05-28 11:16:00

    MILWAUKEE , May 28, 2024 /PRNewswire/ -- Ademi LLP is investigating Atrion (Nasdaq: ATRI) for possible breaches of fiduciary duty and other violations of law in its transaction Nordson. Click here to learn how to join the https://www.ademilaw.com/case/atrion-corporation or call Guri Ademi toll-free at 866-264-3995.

    https://images.financialmodelingprep.com/news/atri-stock-alert-halper-sadeh-llc-is-investigating-whether-the-20240528.jpg
    ATRI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Atrion Corporation Is Fair to Shareholders

    businesswire.com

    2024-05-28 08:14:00

    NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Atrion Corporation (NASDAQ: ATRI) to Nordson Corporation for $460.00 per share in cash is fair to Atrion shareholders. Halper Sadeh encourages Atrion shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Atrion and i.

    https://images.financialmodelingprep.com/news/atrion-corporation-enters-into-merger-agreement-with-nordson-corporation-20240528.jpg
    Atrion Corporation Enters Into Merger Agreement with Nordson Corporation

    globenewswire.com

    2024-05-28 07:24:00

    ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million. The transaction enterprise value reflects a multiple of 20.2 times Atrion's 2023 EBITDA, and the $460 per share price represents a 15% premium to Atrion's 90-day average daily volume-weighted average stock price.

    https://images.financialmodelingprep.com/news/nordson-corporation-announces-agreement-to-acquire-atrion-corporation-a-20240528.jpg
    Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies

    businesswire.com

    2024-05-28 07:00:00

    WESTLAKE, Ohio--(BUSINESS WIRE)--Nordson Corporation (Nasdaq: NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (Nasdaq: ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. This reflects a valuation of 15X Atrion's 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. The acquisition expands Nordson.